Large-scale testing (Phase 3)Study completedNCT02178592
What this trial is testing
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 113